Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing's syndrome.

Abstract

For the diagnosis of Cushing' s syndrome (CS), the overnight 1 mg dexamethasone suppression test (DST) has been widely used as a standard low-dose DST. However, it is evident that 1 mg DST may not be sensitive enough to detect CS when the cortisol cut-off concentration is 5 microg/dL. Therefore, we developed and validated 0.5 mg DST as a new screening… (More)

Topics

Cite this paper

@article{Oki2009DevelopmentAV, title={Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing's syndrome.}, author={Yutaka Oki and Kozo Hashimoto and Yukio Hirata and Yasumasa Iwasaki and Takeshi Nigawara and Masaru Doi and Satoru Sakihara and Kazunori Kageyama and Toshihiro Suda}, journal={Endocrine journal}, year={2009}, volume={56 7}, pages={897-904} }